Results 191 to 200 of about 267,683 (225)

NAFLD, diabete tipo 2, malattia cardiovascolare?

2018
La steatosi epatica non alcolica (NAFLD) è attualmente l’epatopatia cronica più comune nella pratica clinica. La prevalenza della NAFLD è assai elevata nel diabete tipo 2 (T2D), essendo presente in oltre il 60–70% di tali pazienti. In questa breve rassegna discuteremo le evidenze clinico-epidemiologiche che suggeriscono una significativa ...
A Mantovani, R Rigolon, TURINO, TERESA, I Pichiri, G Targher   +4 more
openaire   +1 more source

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis

Chemical Reviews, 2021
Phuong H Nguyen, Ayyalusamy Ramamoorthy, Bikash Sahoo   +2 more
exaly  

Diabetes mellitus tipo 2

2021
openaire   +1 more source

Wearable Electrochemical Glucose Sensors in Diabetes Management: A Comprehensive Review

Chemical Reviews, 2023
Tamoghna Saha, Rafael Del Caño, Shichao Ding   +2 more
exaly  

Gut microbiota in human metabolic health and disease

Nature Reviews Microbiology, 2020
Yong Fan, Oluf Borbye Pedersen
exaly  

The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments

Nature Reviews Gastroenterology and Hepatology, 2021
Giovanni Targher, Christopher D Byrne, Michael Roden   +2 more
exaly  

Hydrogels in Emerging Technologies for Type 1 Diabetes

Chemical Reviews, 2021
Alexander U Ernst, Long-Hai Wang, Kaavian Shariati   +2 more
exaly  

Prevenzione del diabete tipo 2

2020
Falbo, Elisabetta, Ferrante, Marica
openaire   +1 more source

Diabetes and Cancer: A Consensus Report

Ca-A Cancer Journal for Clinicians, 2010
Edward Giovannucci, Michael N Pollak, Douglas Yee   +2 more
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly